Clinical trials are ongoing for cancer patients who have solid tumors that have a specific genetic abnormality called an NRG1 Fusion.

Do you or someone you know have cancer with an NRG1 gene fusion? Here you’ll find information about Merus’ clinical trial for MCLA-128, an experimental medicine, for cancer patients with solid tumors with an NRG1 Fusion. You can also learn about the science behind MCLA-128.

Back to Top

This links to an external website. Merus is not responsible for any third party content.